Browse studies

Find your next paid study

499 recruiting studies matching your filters

A Phase I, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Pharmacokinetics of AZD0543 in Healthy Adults

The purpose of this study is to assess the safety and PK of AZD0543 compared to placebo in healthy adults 18 to 55 years of age. AZD0543 or placebo will be adm…

Human Metapneumovirus Infection

Estimated

~$10 – $7,500

AstraZenecaNCT07824622

An Open Label, Multi-Center, Retrospective and Prospective Evaluation of Shoulder Arthroplasty Clinical and Radiographic Outcomes

The objective of this study is to collect and evaluate long-term clinical and radiographic outcomes data in order to better understand the safety and performan…

Osteo Arthritis ShouldersOsteonecrosisRotator Cuff Tears+6 more

Estimated

~$10 – $1,125

ExactechNCT05603728

Feasibility and Acceptability of Point of Care Rapid Syphilis Testing Among Patients Seeking Family Planning Services in Hawai'i

The purpose of the study is to see if rapid syphilis testing at the time of a family planning (contraception or abortion) visit is acceptable and practical for…

Syphilis Infection

Documented

$50

Queen's Medical CenterNCT07358949

ALPCO Syphilis-T and Syphilis-NT CLIA Kits: Detection of Antibodies to Treponema Pallidum and Against Lipoidal Antigens in Human Serum and Plasma

This study will evaluate the clinical performance of two investigational diagnostic kits developed by ALPCO: the Syphilis-T CLIA Kit and the Syphilis-NT CLIA K…

Treponema PallidumTreponema Pallidum InfectionSyphilis Infection+4 more

Estimated

~$10 – $1,125

American Laboratory Products CompanyNCT07089836

Phase 4

Comparison of the Immune Response After Administration of 2 vs. 3 Doses of the FDA-approved 9-Valent HPV Vaccine Among Women 27-45 Years of Age

The goal of this clinical trial is to compare a 2-dose and 3-dose series of 9vHPV vaccine among 27-45-year-old females to assess if 2 doses elicit a noninferio…

ImmunizationHPV InfectionHuman Papillomavirus

Estimated

~$10 – $6,250

The University of Texas Medical Branch, GalvestonNCT05672927

Phase 3

An Interventional Phase 3, Open-label, Two-cohort Study to Investigate the Efficacy and Safety of Fosmanogepix in Adult Patients With Invasive Mold Infections Caused by Aspergillus Spp., Fusarium Spp., Lomentospora Prolificans, Mucorales Fungi, or Other Multidrug Resistant Molds

The purpose of this study is to evaluate the efficacy and safety of fosmanogepix (administered IV or oral) for the treatment of adult patients with invasive mo…

Invasive Mold Infections

Estimated

~$10 – $8,750

Basilea PharmaceuticaNCT06925321

Observational

Investigation of the Delve Detect Cerebrospinal Fluid (CSF) Metagenomic Next-generation Sequencing (mNGS) Test When Used for the Initial Diagnostic Workup of Patients With Suspected Central Nervous System (CNS) Infection

Delve Bio, Inc. is a developer of novel mNGS tests with the goal of aiding in the diagnosis of infectious diseases in several clinical indications that may not…

Central Nervous System Infection

Estimated

~$10 – $8,750

Delve Bio, Inc.NCT07435649

Phase 2

A Phase 2, Double-blind, Randomized, Active-controlled Evaluation of the Safety, Tolerability, Pharmacokinetics and Efficacy of LBP-EC01 in the Treatment of Acute Uncomplicated Urinary Tract Infection Caused by Drug Resistant E. Coli

This is a Phase 2 superiority study of LBP-EC01, a recombinant bacteriophage cocktail, with an initial open-label 3-arm pharmacokinetic (PK) lead-in portion of…

Urinary Tract Infections

Estimated

~$10 – $8,750

Locus BiosciencesNCT05488340

Phase 1

Phase 1 Randomized Double-Blind Placebo-Controlled Safety Study of MucoCept-CVN (Lactobacillus Jensenii 1153-1666) Administered Vaginally to Healthy Women

MucoCept-CVN uses a Lactobacillus strain native to the human vagina that is modified into a live biotherapeutic product (LBP) that continuously expresses a pot…

HIV -1 Infection

Estimated

~$10 – $7,500

Craig Cohen, MD, MPHNCT07181486

Observational

Urine Resazurin Reduction Ratio and Phenotypic Antibiotic Susceptibility Testing: A Rapid Diagnostic Tool for Urinary Tract Infection and Lower Urinary Tract Dysfunction Using a Catheter

Patients who seek care through MedStar National Rehab Hospital's clinic believing they have a UTI will be enrolled in this trial. They will be pre-screened aft…

Neurogenic Bladder DisorderLower Urinary Tract DisorderUrinary Tract Infection (Diagnosis)

Estimated

~$10 – $7,500

Medstar Health Research InstituteNCT07784829

Single Dose Amikacin for Uncomplicated Cystitis in the Emergency Department (ED): A Feasibility Study

The purpose of this study is to determine if a single dose of amikacin (a type of antibiotic) can be used to effectively treat emergency department patients wi…

Urinary Tract Infections

Estimated

~$10 – $1,125

Antonios LikourezosNCT05227937

Diagnosis and Management of Inflammatory and Infectious Diseases

This protocol is being established to cover the evaluation of patients with inflammatory and/or infectious diseases which are not covered under previously exis…

InfectionInflammation

Estimated

~$10 – $675

National Institute of Allergy and Infectious Diseases (NIAID)NCT00557726